Role of apigenin in targeting metabolic syndrome: A systematic review

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 100

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-27-5_001

تاریخ نمایه سازی: 19 اسفند 1402

چکیده مقاله:

Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that has a high prevalence worldwide. Apigenin is a flavonoid present in several vegetables and fruits and has anti-inflammatory, anti-oxidant, and anti-MetS properties. This study aims to systematically review the effects of apigenin against MetS and the relevant molecular and cellular mechanisms of action, pharmacokinetics features, and potential structure-activity relationship. Electronic databases including Scopus, PubMed, Science Direct and Cochrane Library were searched for in vivo, and in vitro, and human studies with the following keywords: “apigenin” and “metabolic syndrome or insulin resistance syndrome”, “fatty liver”, “hypertension or blood pressure”, “diabetes or blood glucose”, “dyslipidemia”, “heart or cardiovascular ” and “obesity” in title/abstract. Data were collected from ۲۰۰۰ until ۲۰۲۱ (up to April). Only papers published in the English language were included. Forty-six full-text articles out of ۱۰۱۶ retrieved papers were reviewed and underwent quality assessment by investigators. Anti-obesity activity of apigenin is mainly through attenuating adipocyte differentiation by suppressing the mitotic clonal expansion and the adipogenesis-related factors. Its anti-diabetic effects can be exerted through inhibition of protein tyrosine phosphatase۱B expression, maintaining the activity of anti-oxidant enzymes, reducing intracellular ROS production, cellular DNA damage, protein carbonylation, and attenuating β-cell apoptosis. Moreover, apigenin could attenuate dyslipidemia and subsequent atherosclerotic conditions through down-regulating sterol regulatory element-binding proteins (SREBP)-۱c, SREBP-۲, stearyl-CoA desaturase-۱, and ۳-hydroxy-۳-methyl-glutaryl-CoA reductase. Apigenin as a dietary bioactive compound would be a promising candidate for improving MetS and its components.

نویسندگان

Behjat Javadi

Department of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Zahra Sobhani

Department of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Saklayen MG. The global epidemic of the metabolic syndrome. Curr ...
  • McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic ...
  • Engin A. The definition and prevalence of obesity and metabolic ...
  • Rochlani Y, Pothineni V, Kovelamudi S, Mehta JL. Metabolic syndrome: ...
  • Hopps E, Noto D, Caimi G, Averna M. A novel ...
  • Khaafi M, Tayarani-Najaran Z, Javadi B. Cinnamaldehyde as a promising ...
  • Kim B, Feldman EL. Insulin resistance as a key link ...
  • Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med ۲۰۱۶; ۲۶: ...
  • Rao T, Tan Z, Peng J, Guo Y, Chen Y, ...
  • Javadi B, Sahebkar A, Emami SA. Medicinal plants for the ...
  • Highlights of prescribing information [Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/۲۰۲۲/۲۱۳۹۹۴s۰۰۴lbl.pdf ...
  • Newman DJ, Cragg GM. Natural products as sources of new ...
  • Ren N, Kim E, Li B, Pan H, Tong T, ...
  • Russo B, Picconi F, Malandrucco I, Frontoni S. Flavonoids and ...
  • Madunić J, Madunić IV, Gajski G, Popić J, Garaj-Vrhovac V. ...
  • Tang D, Chen K, Huang L, Li J. Pharmacokinetic properties ...
  • Zhang J, Liu D, Huang Y, Gao Y, Qian S. ...
  • Ono M, Fujimori K. Antiadipogenic effect of dietary apigenin through ...
  • Jung UJ, Cho YY, Choi MS. Apigenin ameliorates dyslipidemia, hepatic ...
  • Yang M, Jiang Zh, Li C, Zhu YJ, Li Z, ...
  • Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. ...
  • Ulrey A, Kolle S, Landsiedel R, Hill E. How a ...
  • Myers J, Kokkinos P, Nyelin E. Physical activity, cardiorespiratory fitness, ...
  • Reddy P, Lent-Schochet D, Ramakrishnan N, McLaughlin M, Jialal I. ...
  • Festa A, D’Agostino R Jr, Howard G, Mykkanen, Tracy RP, ...
  • Hong YN, Chun J, Kim YS. Anti-adipogenic activity of Carduus ...
  • Guo X, Liu J, Cai S, Wang O, Ji B. ...
  • Feng X, Weng D, Zhou F, Owen YD, Qin H, ...
  • Gentile D, Fornai M, Colucci R, Pellegrini C, Tirotta E, ...
  • Escande C, Nin V, Price NL, Capellini V, Gomes AP, ...
  • Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P. Metabolic adaptations ...
  • Sun YS, Qu W. Dietary Apigenin promotes lipid catabolism, thermogenesis, ...
  • Okla M, Al Madani JO, Chung S, Alfayez M. Apigenin ...
  • Aranaz P, Navarro-Herrera D, Zabala M, Romo-Hualde A, López-Yoldi M, ...
  • Su T, Huang C, Yang C, Jiang T, Su J, ...
  • Wu L, Guo T, Deng R, Liu L, Yu Y. ...
  • Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and ...
  • Ali MY, Jannat S, Rahman MM. Investigation of C-glycosylated apigenin ...
  • Cho H. Protein tyrosine phosphatase ۱B (PTP۱B) and obesity. Vitam ...
  • Panda S, Kar A. Apigenin (۴ ‘, ۵, ۷‐trihydroxyflavone) regulates ...
  • Rauter AP, Martins A, Borges C, Mota‐Filipe H, Pinto R, ...
  • Wang N, Yi WJ, Tan L, Zhang JH, Xu J, ...
  • Suh KS, Oh S, Woo JT, Kim SW, Kim JW, ...
  • Fan JF, Johnson MH, Lila MA, Yousef G, de Mejia ...
  • Bumke-Vogt C, Osterhoff MA, Borchert A, Guzman-Perez V, Sarem Z, ...
  • Li K, Yao F, Xue Q, Fan H, Yang L, ...
  • Dostálek P, Karabín M, Jelínek L. Hop phytochemicals and their ...
  • Fujii N, Narita T, Okita N, Kobayashi M, Furuta Y, ...
  • Kim KT, Yeo EJ, Moon SH, Cho SG, Han YS, ...
  • Zhang K, Song W, Li D, Jin X. Apigenin in ...
  • Wang N, Westerterp M. ABC transporters, cholesterol efflux, and implications ...
  • Ren K, Jiang T, Zhou HF, Liang Y, Zhao GJJ. ...
  • Chen L, Zheng L, Chen P, Liang G. Myeloid differentiation ...
  • Wong TY, Tan YQ, Lin SM, Leung LK. Apigenin and ...
  • Wong TY, Tan YQ, Lin SM, Leung LKJ. Co-administrating apigenin ...
  • Feng X, Yu W, Li X, Zhou F, Zhang W, ...
  • Wang F, Liu JC, Zhou RJ, Zhao X, Liu M, ...
  • Lv Y, Gao X, Luo Y, Fan W, Shen T, ...
  • Yue S, Xue N, Li H, Huang B, Chen Z, ...
  • Sui H, Yan W, Geng G. Effect of apigenin on ...
  • Zhu ZY, Gao T, Huang Y, Xue J, Xie ML. ...
  • Zhang YH, Park YS, Kim TJ, Fang LH, Ahn HY, ...
  • Jing Y, Chen R, Dong M, Liu Y, Hou X, ...
  • Qin W, Ren B, Wang S, Liang S, He B, ...
  • Sukandar EY, Ridwan A, Sukmawan YP. Vasodilation effect of oleanolic ...
  • Loizzo MR, Said A, Tundis R, Rashed K, Statti GA, ...
  • Paredes MD, Romecín P, Atucha NM, O’Valle F, Castillo J, ...
  • Buwa CC, Mahajan UB, Patil CR, Goyal SN. Apigenin attenuates ...
  • Zeng P, Liu B, Wang Q, Fan Q, Diao JX, ...
  • Gao HL, Yu XJ, Hu HB, Yang QW, Liu KL, ...
  • Zhang P, Mak JC, Man RY, Leung SW. Flavonoids reduces ...
  • Loizzo M, Lecce GD, Boselli E, Menichini F, Frega N. ...
  • He Y, Xia Z, Yu D, Wang J, Jin L, ...
  • Ding Sm, Zhang Zh, Song J, Cheng Xd, Jiang J, ...
  • DeRango-Adem EF, Blay J. Does oral apigenin have real potential ...
  • Wan L, Guo C, Yu Q, Li Y, Wang Xia, ...
  • Gradolatto A, Basly JP, Berges R, Teyssier C, Chagnon MC, ...
  • Tang L, Zhou J, Yang CH, Xia BJ, Hu M, ...
  • Sen K, Banerjee S, Mandal M. Dual drug loaded liposome ...
  • نمایش کامل مراجع